Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postpartum anti-D: can we safely reduce the dose?

Bradley M Augustson1, Elizabeth A Fong, Dianne E Grey

  • 1PathWest Laboratory Medicine WA, Perth, Western Australia, Australia. bradley.augustson@health.wa.gov.au

The Medical Journal of Australia
|June 29, 2006
PubMed
Summary

This study suggests reducing the postpartum anti-D dose to 250 IU for Rhesus D-negative women. Quantifying fetomaternal hemorrhage (FMH) with flow cytometry supports this dose reduction, conserving anti-D supply.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of 1- and 2-unit red blood cell transfusions on continuously monitored vital signs: a longitudinal study.

Blood transfusion = Trasfusione del sangue·2026
Same author

Leukaemia Flow Cytometry in Yemen.

International journal of laboratory hematology·2026
Same author

Imaging Flow Cytometry Detection of Cytogenetic Abnormalities in Circulating CD34+ Cells Predicts Leukemic Transformation in Myelofibrosis.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2026
Same author

Imaging Flow Cytometric Assessment of del(17p) and amp(1q21) in Circulating Plasma Cells of Myeloma Patients.

Current protocols·2026
Same author

Megakaryocyte emperipolesis in myeloproliferative neoplasms: Are neutrophils friends or foes?

Journal of leukocyte biology·2025
Same author

Flow cytometric detection of BCR::ABL1 in T-lymphocytes in chronic myeloid leukaemia.

Pathology·2025

Area of Science:

  • Immunology
  • Obstetrics
  • Hematology

Background:

  • Prophylactic anti-D immunoglobulin is crucial for Rhesus D-negative women to prevent hemolytic disease of the newborn.
  • Accurate dosing of anti-D is essential for efficacy and resource conservation.

Purpose of the Study:

  • To evaluate the feasibility of reducing the standard postpartum anti-D dose.
  • To determine if a lower dose of anti-D would be sufficient based on fetomaternal hemorrhage (FMH) volumes.

Main Methods:

  • A retrospective audit of 5148 Rhesus D-negative women was conducted.
  • Fetomaternal hemorrhage (FMH) volume was quantified using flow cytometry.
  • The volume of FMH was assessed to determine adequate anti-D prophylaxis.

Related Experiment Videos

Main Results:

  • Over 98.5% of women had an FMH volume less than 2.5 mL.
  • Only 0.4% of cases exhibited an FMH volume of 6.0 mL or greater.
  • A 250 IU dose of anti-D would have been sufficient for 98.5% of the studied population.

Conclusions:

  • The study supports a reduction in the routine postpartum anti-D dose from 625 IU to 250 IU.
  • Implementing this dose reduction, particularly when flow cytometric FMH quantitation is available, is recommended.
  • This strategy can ensure the continued availability of anti-D, a valuable blood product with limited supply.